Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Resistance to skin carcinogenesis in PARP-1 knockout mice due to a defective inflammatory response

D. Martin-Oliva

Med Sci Monit 2003; 9(1): 39-0 :: ID: 15102

Abstract

It is well known that inflammation is a key component in the initiation and progression of epithelial cancer [1]. In a recent studies [2] we have established that the absence of PARP-1 is able to slow down tumour formation and to increase the lifespan of p53 deficient mice. We and others have shown that PARP-1 is a transcriptional co-activator of NF-kB and PARP-1 knockout as a result of a diminished release of pro-inflammatory mediators, including NO [3,4]. In the present report we have studied the susceptibility to skin carcinogenesis in mice deficient for poly(ADP-ribose) polymerase-1. In PARP-1–/– mice development of skin tumours induced by initiation with DMBA and promotion with TPA is strongly delayed, and the final number of tumour-bearing mice and total tumour number were significantly decreased in genetically deficient mice for PARP-1. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. Nonetheless, epidermis of PARP-1–/– mice did not show increased proliferation rates. Derregulated NF-kB has been proven to be a hallmark for tumorigenesis together with the concomitant release of early inflammatory mediators, such as TNF-a. In the absence of PARP-1 NF-kB activation and induction of TNF-a did not take place during the initiation of tumour development in cell extracts from the epidermis of the carcinogen-treated area. In view of the important roles of NF-kB in tumour promotion/progression, these results suggest that inhibition of tumour development by the abolition of PARP-1 may be mediated by impairing signal transduction pathways leading to activation of NF-kB. References: 1.Correa P: Cancer Res, 1992; 52; 6735-6740 2.Conde C, Mark M, Oliver FJ et al: EMBO Journal, 2001; 20: 3535-3543 3.Oliver FJ, Ménissier de Murcia J, Nacci C et al: EMBO Journal, 1999; 18: 4446-4454 4.Hassa PO, Covic M, Hasan S et al: J Biol Chem, 2001 Dec 7; 276(49): 45588-97

Keywords: PARP-1 knockout mice, skin carcinogenesis, NF-kB, TNF-a

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Use of The Mirror-Image Technique for Patient-Specific Reconstruction of Cuboid Fractures

Med Sci Monit In Press; DOI: 10.12659/MSM.947437  

Laboratory Research  

Retention of 3-D-Printed, Milled, and Conventionally Fabricated Occlusal Splints

Med Sci Monit In Press; DOI: 10.12659/MSM.947342  

Review article  

A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitor...

Med Sci Monit In Press; DOI: 10.12659/MSM.949300  

Clinical Research  

Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological Surgery

Med Sci Monit In Press; DOI: 10.12659/MSM.947088  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,932,846

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,905

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   29,808

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   23,790

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750